Literature DB >> 19211496

Magnesium sulfate for the treatment of eclampsia: a brief review.

Anna G Euser1, Marilyn J Cipolla.   

Abstract

BACKGROUND AND
PURPOSE: Magnesium sulfate is used extensively for prevention of eclamptic seizures. Empirical and clinical evidence supports the effectiveness of magnesium sulfate; however, questions remain as to its safety and mechanism. This review summarizes current evidence supporting the possible mechanisms of action and several controversies for magnesium sulfate treatment. SUMMARY OF REVIEW: Several mechanisms are presented, including the effects of magnesium sulfate on peripheral and cerebral vasodilation, blood-brain barrier protection, and as an anticonvulsant.
CONCLUSIONS: Though the specific mechanisms of action remain unclear, the effect of magnesium sulfate in the prevention of eclampsia is likely multi-factorial. Magnesium sulfate may act as a vasodilator, with actions in the peripheral vasculature or the cerebrovasculature, to decrease peripheral vascular resistance or relieve vasoconstriction. Additionally, magnesium sulfate may also protect the blood-brain barrier and limit cerebral edema formation, or it may act through a central anticonvulsant action.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211496      PMCID: PMC2663594          DOI: 10.1161/STROKEAHA.108.527788

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  91 in total

1.  Neuromuscular transmission studies in preeclamptic women receiving magnesium sulfate.

Authors:  J Ramanathan; B M Sibai; R Pillai; J J Angel
Journal:  Am J Obstet Gynecol       Date:  1988-01       Impact factor: 8.661

2.  Severe preeclampsia/eclampsia: hypertensive encephalopathy of pregnancy?

Authors:  J D Easton
Journal:  Cerebrovasc Dis       Date:  1998 Jan-Feb       Impact factor: 2.762

3.  Use of anticonvulsants in eclampsia and pre-eclampsia: survey of obstetricians in the United Kingdom and Republic of Ireland.

Authors:  A M Gülmezoglu; L Duley
Journal:  BMJ       Date:  1998-03-28

4.  Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure.

Authors:  R S Goldman; S M Finkbeiner
Journal:  N Engl J Med       Date:  1988-11-03       Impact factor: 91.245

5.  Structural and functional variations in capillary systems within the brain.

Authors:  J Fenstermacher; P Gross; N Sposito; V Acuff; S Pettersen; K Gruber
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

6.  Ultrastructure of the blood-brain barrier in the rabbit.

Authors:  R Sedlakova; R R Shivers; R F Del Maestro
Journal:  J Submicrosc Cytol Pathol       Date:  1999-01

7.  Magnesium sulfate treatment decreases N-methyl-D-aspartate receptor binding in the rat brain: an autoradiographic study.

Authors:  M Hallak; R F Berman; S M Irtenkauf; C A Janusz; D B Cotton
Journal:  J Soc Gynecol Investig       Date:  1994 Jan-Mar

8.  Myosin light chain phosphorylation: modulation of basal and agonist-stimulated venular permeability.

Authors:  Y Yuan; Q Huang; H M Wu
Journal:  Am J Physiol       Date:  1997-03

Review 9.  Magnesium sulfate therapy in preeclampsia and eclampsia.

Authors:  A G Witlin; B M Sibai
Journal:  Obstet Gynecol       Date:  1998-11       Impact factor: 7.661

10.  Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: a preliminary report.

Authors:  G R Thurnau; D B Kemp; A Jarvis
Journal:  Am J Obstet Gynecol       Date:  1987-12       Impact factor: 8.661

View more
  66 in total

1.  IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?

Authors:  Babbette Lamarca; Justin Brewer; Kedra Wallace
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2011-07-01

Review 2.  Pregnancy-related liver disorders.

Authors:  Ashish Goel; Kapil D Jamwal; Anup Ramachandran; Kunissery A Balasubramanian; Chundamannil E Eapen
Journal:  J Clin Exp Hepatol       Date:  2013-03-16

Review 3.  Osmoregulation and epithelial water transport: lessons from the intestine of marine teleost fish.

Authors:  Jonathan M Whittamore
Journal:  J Comp Physiol B       Date:  2011-07-07       Impact factor: 2.200

4.  Seizures in Women with Preeclampsia: Mechanisms and Management.

Authors:  Marilyn J Cipolla; Richard P Kraig
Journal:  Fetal Matern Med Rev       Date:  2011-05

5.  Reduced expression of the epidermal growth factor signaling system in preeclampsia.

Authors:  D R Armant; R Fritz; B A Kilburn; Y M Kim; J K Nien; N J Maihle; R Romero; R E Leach
Journal:  Placenta       Date:  2014-12-27       Impact factor: 3.481

6.  The Impact of Magnesium Sulfate Therapy on Angiogenic Factors in Preeclampsia.

Authors:  Mary A Vadnais; Sarosh Rana; Hayley S Quant; Saira Salahuddin; Laura E Dodge; Kee-Hak Lim; S Ananth Karumanchi; Michele R Hacker
Journal:  Pregnancy Hypertens       Date:  2012-01-01       Impact factor: 2.899

7.  Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, L-NAME and L-arginine worsen.

Authors:  Maria Medvidovic-Grubisic; Vasilije Stambolija; Danijela Kolenc; Jadranka Katancic; Tamara Murselovic; Ivna Plestina-Borjan; Sanja Strbe; Domagoj Drmic; Ivan Barisic; Aleksandra Sindic; Sven Seiwerth; Predrag Sikiric
Journal:  Inflammopharmacology       Date:  2017-02-16       Impact factor: 4.473

8.  Reversible cerebral vasoconstriction syndrome accompanied by hypomagnesemia.

Authors:  Keiichi Hokkoku; Yuichi Furukawa; Junpei Yamamoto; Yudai Uchida; Masahiro Sonoo
Journal:  Neurol Sci       Date:  2018-02-17       Impact factor: 3.307

Review 9.  Delayed neurological deterioration after subarachnoid haemorrhage.

Authors:  R Loch Macdonald
Journal:  Nat Rev Neurol       Date:  2013-12-10       Impact factor: 42.937

10.  Posterior Reversible Encephalopathy Syndrome in an Eclamptic Patient After Cardiac Arrest; Case Report and Literature Review.

Authors:  Mehtap Honca; Aytaç Polat; Eyüp Horasanlı
Journal:  Turk J Anaesthesiol Reanim       Date:  2014-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.